Drug Type Mesenchymal stem cell therapy  | 
Synonyms-  | 
Target  | 
Action stimulants  | 
Mechanism FPR2 stimulants(N-formyl peptide receptor 2 stimulants)  | 
Therapeutic Areas  | 
Active Indication  | 
Inactive Indication-  | 
Originator Organization  | 
Active Organization  | 
Inactive Organization-  | 
License Organization-  | 
Drug Highest PhasePreclinical  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Fibrosis, Liver | Preclinical | South Korea   | 01 Aug 2025 | |
| Fibrosis, Liver | Preclinical | South Korea   | 01 Aug 2025 | 





